My watch list  

22 Current news about the topic opioids


You can refine your search further. Select from the filter options on the left to narrow down your results.

BioXell and Lay Line Genomics announce License Agreement for Anti-TrkA Antibody against Pain


BioXell S.p.A. and Lay Line Genomics S.p.A. (LLG) announced an exclusive, worldwide license agreement for the development of MNAC13, a novel humanized monoclonal antibody that binds to TrkA receptors, blocking the action of Nerve Growth Factor (NGF), a key mediator of pain. According to the ...


Wyeth and Progenics Pharmaceuticals Announce Worldwide Collaboration to Develop and Commercialize Methylnaltrexone


Wyeth Pharmaceuticals, a division of Wyeth and Progenics Pharmaceuticals, Inc. announced that they have entered into an exclusive, worldwide agreement for the joint development and commercialization of methylnaltrexone (MNTX) for the treatment of opioid-induced side effects, including ...


Page 3 From 3
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE